VREO.CN - Vireo Health International Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
1.4600
+0.0200 (+1.39%)
As of 11:39AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close1.4400
Open0.0000
Bid1.4100 x 0
Ask1.4500 x 0
Day's Range1.3200 - 1.4700
52 Week Range1.0500 - 6.8700
Volume141,141
Avg. Volume249,518
Market Cap124.469M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2470
Earnings DateNov 26, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    CB2 Insights Selected by Vireo Health to Support Medical Cannabis Clinical Trial

    CB2 chosen to advance application with the US FDA for study on safety and efficacy of cannabis-based topical treatments by leading multistate operator, Vireo. Project marks the start of the clinical trial process for Vireo’s topical creams, lotions and gels to be used by patients for pain management. Company will develop full protocols and manage Investigational New Drug (IND) application on behalf of Vireo and will work with the FDA towards approvals.

  • Vireo Health Employees Ratify First Cannabis Union Contract in Maryland History with UFCW Local 27
    PR Newswire

    Vireo Health Employees Ratify First Cannabis Union Contract in Maryland History with UFCW Local 27

    United Food and Commercial Workers Local 27 (UFCW27) and Vireo Health International, Inc. ("Vireo" or "the Company") (CNSX: VREO; OTCQX: VREOF), today announced that workers at its wholly-owned subsidiary, MaryMed, LLC ("MaryMed"), voted overwhelmingly to ratify a Collective Bargaining Agreement and officially join the ranks of UFCW Local 27.

  • Vireo Health Launches Lower-THC 'LiteBud' Brand
    PR Newswire

    Vireo Health Launches Lower-THC 'LiteBud' Brand

    Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced the launch of LiteBud, a patent-pending line of consistently formulated, lower-Tetrahydrocannabinol (THC) cannabis products that are designed to meet the needs of cannabis consumers seeking a more consistent, controlled and mild experience.

  • Vireo Health CEO and Founder Kyle Kingsley, M.D. Signs CEO Action for Diversity & Inclusion™ Pledge
    PR Newswire

    Vireo Health CEO and Founder Kyle Kingsley, M.D. Signs CEO Action for Diversity & Inclusion™ Pledge

    Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-founded, science-focused multi-state cannabis company today announced that the Company's CEO and Founder Kyle Kingsley, M.D. has signed the CEO Action for Diversity & Inclusion™ Pledge.

  • Benzinga

    Vireo Health Trades Down On Q3 Results, CEO Sees 'Clear Path To Profitability'

    Cannabis company Vireo Health International, Inc. (CNSX: VREO) (OTC: VREOF) reported third-quarter financial results Wednesday, posting revenue of $8 million, up 62% year-over-year. Vireo posted a quarterly net loss of $14.6 million versus net income of $14,890 in the corresponding period of the prior year. The adjusted net loss for the quarter was $4.9 million, up from a loss of $2 million year-over-year.

  • Vireo Health to Report Third Quarter 2019 Results on November 27, 2019
    PR Newswire

    Vireo Health to Report Third Quarter 2019 Results on November 27, 2019

    MINNEAPOLIS , Nov. 18, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, ...

  • Vireo Health Names Shaun Nugent Chief Financial Officer
    PR Newswire

    Vireo Health Names Shaun Nugent Chief Financial Officer

    Nugent Brings 25 Years of Financial Experience Having Previously Served as CFO at Life Time Fitness, Champps Entertainment, and Sun Country Airlines MINNEAPOLIS , Nov. 14, 2019 /PRNewswire/ -- Vireo Health ...

  • Vireo Health Appoints Amber Shimpa to the New Role of Chief Administrative Officer
    PR Newswire

    Vireo Health Appoints Amber Shimpa to the New Role of Chief Administrative Officer

    MINNEAPOLIS, Nov. 13, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), the leading science-focused multi-state cannabis company, today announced that Amber Shimpa will be transitioning to the newly created role of Chief Administrative Officer ("CAO") on December 2, 2019. As CAO, Ms. Shimpa will continue to lead the Company's human resources and business administration teams and further drive the integration of people and culture for Vireo.

  • Ex-Canopy CEO Bruce Linton joins U.S. cannabis company Vireo Health
    MarketWatch

    Ex-Canopy CEO Bruce Linton joins U.S. cannabis company Vireo Health

    Shares of Vireo Health International Inc. rocketed 26% Thursday, after the U.S. cannabis company said it has named cannabis entrepreneur Bruce Linton as executive chairman.

  • MarketWatch

    UPDATE: Canopy Growth ex-CEO Bruce Linton to become executive chairman of Vireo Health, stock soars

    Bruce Linton, the former co-chief executive and founder of Canadian cannabis company Canopy Growth Corp. , has been named executive chairman of Vireo Health International Inc. , a doctor-led multi-state cannabis company based in Minneapolis. Linton will join the company's board, will work closely with a Vireo CEO and Founder Kyle Kingsley and lead the company's capital markets activity and partnerships and shape its strategy. Linton will be compensated in the form of incentive warrants, to be paid in three tranches, according to Vireo. The company's U.S. listed stock was last up 27% on the news, but has fallen 36% in the last three months, while the ETFMG Alternative Harvest ETF has fallen 32% and the S&P 500 has gained 23%.

  • CNW Group

    IIROC Trade Resumption - VREO

    IIROC Trade Resumption - VREO

  • Vireo Health Names Bruce Linton as Executive Chairman
    PR Newswire

    Vireo Health Names Bruce Linton as Executive Chairman

    MINNEAPOLIS, Nov. 7, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced that it has named Bruce Linton to the role of Executive Chairman. As Executive Chairman, Mr. Linton will be actively involved in the Company's business.

  • CNW Group

    IIROC Trading Halt - VREO

    IIROC Trading Halt - VREO

  • Market Exclusive

    Cannabis Stock News Roundup October 31

    Aurora Cannabis (NYSE: ACB) (TSX: ACB) announced the launch of Ready for Edibles, a national bilingual campaign to educate new and experienced cannabis consumers on responsible consumption and safe storage of edibles products before they become available for sale in December. Core One Labs (CSE: COOL) (OTCQX: CLABF) (Frankfurt: LD6) announced that its board of directors […]The post Cannabis Stock News Roundup October 31 appeared first on Market Exclusive.

  • Vireo Health Launches New 'Green Goods' Retail Dispensary Brand in Scranton, Pennsylvania
    PR Newswire

    Vireo Health Launches New 'Green Goods' Retail Dispensary Brand in Scranton, Pennsylvania

    MINNEAPOLIS , Oct. 30, 2019 /PRNewswire/ -- Vireo Health International, Inc., ("Vireo" or the "Company") (CSNX: VREO; OTQX: VREOF), a leading physician-founded, science-focused multi-state ...

  • Benzinga

    Vireo Health Offers Dry Flower To Pennsylvania, Maryland Dispensaries With New 1937 Brand

    1937 also represents the company’s first foray into offering dry flower. The brand, named after the Marihuana Tax Act of 1937 which prohibited cannabis in the United States, plans to release a line of concentrates later in the year. Products can be found in dispensaries in Maryland and Pennsylvania.

  • Vireo Health Launches 1937 Cannabis Brand
    PR Newswire

    Vireo Health Launches 1937 Cannabis Brand

    1937 Cannabis features historic cannabis strains and will be available in both dry flower and concentrates MINNEAPOLIS , Oct. 17, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" ...

  • Vireo Health Names Ari Hoffnung Chief Strategy Officer
    PR Newswire

    Vireo Health Names Ari Hoffnung Chief Strategy Officer

    MINNEAPOLIS , Oct. 14, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-founded, science-focused multi-state ...

  • PR Newswire

    Vireo Health Employees Ratify First Cannabis Union Contract in Pennsylvania with UFCW 1776KS

    PHILADELPHIA , Oct. 7, 2019 /PRNewswire/ -- United Food and Commercial Workers Local 1776 Keystone State and Vireo Health International, Inc. ("Vireo") (CNSX: VREO; OTCQX: VREOF), announced that ...

  • Vireo Health to Present at the Canaccord Genuity U.S. Cannabis Symposium
    PR Newswire

    Vireo Health to Present at the Canaccord Genuity U.S. Cannabis Symposium

    MINNEAPOLIS , Oct. 2, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state ...

  • Market Exclusive

    Cannabis Stock News Daily Roundup September 23

    TerrAscend (CSE: TER) (OTCQX: TRSSF) has closed the acquisition of Ilera Healthcare, a permitted cannabis cultivator, processor, and dispensary operators in Pennsylvania. This acquisition expands the company's licensed cannabis footprint to four U.S. states, in addition to its global reach into Canada and Europe. Hemp Technology (OTCPK: CPOW) has signed an agreement to purchase Pettanicals Pet Treats, a […]The post Cannabis Stock News Daily Roundup September 23 appeared first on Market Exclusive.

  • Vireo Health Announces DTC Eligibility for Publicly Traded Shares
    PR Newswire

    Vireo Health Announces DTC Eligibility for Publicly Traded Shares

    MINNEAPOLIS , Sept. 19, 2019 /PRNewswire/ --   Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis ...

  • Benzinga

    Vireo Health Reports Q2 Revenue Up 70% Year-Over-Year

    Cannabis company Vireo Health International, Inc. (CNSX: VREO) (OTC: VREOF) reported second-quarter total revenue of .2 million, up 70% from the same quarter in 2018. Vireo Health had a net loss in the second quarter of around $1.9 million, compared to a net income of $120,080 in the same quarter of 2018. Additional business updates after the second quarter, include promoting Christian Gonzalez to the position of Vice President of enterprise-wide Manufacturing in July and the stock's beginning of trading on the OTCQX Best Market in August.

  • Vireo Health to Report Second Quarter 2019 Results on August 29, 2019
    PR Newswire

    Vireo Health to Report Second Quarter 2019 Results on August 29, 2019

    MINNEAPOLIS , Aug. 21, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading science-focused, multi-state cannabis company, ...

  • Vireo Health Affiliate Given Green Light to Operate Medical Cannabis Processing Facility in Ohio
    PR Newswire

    Vireo Health Affiliate Given Green Light to Operate Medical Cannabis Processing Facility in Ohio

    MINNEAPOLIS, Aug. 15, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), a leading physician-led, science-focused multi-state cannabis company, today announced that the Company's affiliate, Ohio Medical Solutions ("OMS"), was granted a Certificate of Operation by the Ohio Department of Commerce. OMS, which will begin operating immediately, was previously awarded a provisional processing license.